Chemotherapy-Induced IL8 Upregulates MDR1/ABCB1 in Tumor Blood Vessels and Results in Unfavorable Outcome
- 15 July 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (14), 2996-3008
- https://doi.org/10.1158/0008-5472.can-19-3791
Abstract
Tumor endothelial cells (TEC) lining tumor blood vessels actively contribute to tumor progression and metastasis. In addition to tumor cells, TEC may develop drug resistance during cancer treatment, allowing the tumor cells to survive chemotherapy and metastasize. We previously reported that TEC resist paclitaxel treatment via upregulation of ABCB1. However, whether TEC phenotypes are altered by anticancer drugs remains to be clarified. Here we show that ABCB1 expression increases after chemotherapy in urothelial carcinoma cases. The ratio of ABCB1-positive TEC before and after first-line chemotherapy in urothelial carcinoma tissues (n = 66) was analyzed by ABCB1 and CD31 immunostaining. In 42 cases (64%), this ratio increased after first-line chemotherapy. Chemotherapy elevated ABCB1 expression in endothelial cells by increasing tumor IL-8 secretion. In clinical cases, ABCB1 expression in TEC correlated with IL-8 expression in tumor cells after first-line chemotherapy, leading to poor prognosis. In vivo, the ABCB1 inhibitor combined with paclitaxel reduced tumor growth and metastasis compared with paclitaxel alone. Chemotherapy is suggested to cause inflammatory changes in tumors, inducing ABCB1 expression in TEC and conferring drug resistance. Overall, these findings indicate that TEC can survive during chemotherapy and provide a gateway for cancer metastasis. Targeting ABCB1 in TEC represents a novel strategy to overcome cancer drug resistance.Funding Information
- JSPS (JP18H05092)
- JSPS (JP18K09715)
- JSPS (JP19K18549)
- JSPS (JP18H02891)
- JSPS (JP18H02996)
- Japan Agency for Medical Research and Development (JP18ck0106198h0003)
- Japan Agency for Medical Research and Development (JP19ck0106406h0002)
This publication has 49 references indexed in Scilit:
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to ChemotherapyCancer Discovery, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant TumorsThe American Journal of Pathology, 2009
- PrognoScan: a new database for meta-analysis of the prognostic value of genesBMC Medical Genomics, 2009
- A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancerNature Medicine, 2009
- Calcification of Multipotent Prostate Tumor EndotheliumCancer Cell, 2008
- Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptakeJCI Insight, 2006
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002